Order Article Reprints

Claude-Taupin A, Fonderflick L, Gauthier T, Mansi L, Pallandre J-R, Borg C, Perez V, Monnien F, Algros M-P, Vigneron M, et al. ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes. Cells. 2018; 7(12):248. https://doi.org/10.3390/cells7120248

Claude-Taupin, Aurore, Leïla Fonderflick, Thierry Gauthier, Laura Mansi, Jean-René Pallandre, Christophe Borg, Valérie Perez, Franck Monnien, Marie-Paule Algros, Marc Vigneron, and et al. 2018. "ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes" Cells 7, no. 12: 248. https://doi.org/10.3390/cells7120248

Claude-Taupin, A., Fonderflick, L., Gauthier, T., Mansi, L., Pallandre, J.-R., Borg, C., Perez, V., Monnien, F., Algros, M.-P., Vigneron, M., Adami, P., Delage-Mourroux, R., Peixoto, P., Herfs, M., Boyer-Guittaut, M., & Hervouet, E. (2018). ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes. Cells, 7(12), 248. https://doi.org/10.3390/cells7120248